Keith Yazmir Takes the Helm as President at Maslansky + Partners

Language strategy consultancy Maslansky + Partners has elevated founding partner Keith Yazmir to President as part of a broader expansion of its executive leadership team, with a focus on accelerating growth across healthcare and synthetic research.

Yazmir, who has spent 20 years with the firm, will lead growth initiatives while working to strengthen integration across Omnicom Public Relations Group and the wider Omnicom network. His professional background spans executive communications and marketing, with experience across the pharmaceutical, technology, automotive and travel sectors.

Strengthening Healthcare Expertise

As part of the leadership expansion, the Omnicom-owned agency has promoted Katherine Hettrich and Amanda Kealey to partners, reinforcing its capabilities in the life sciences sector.

Hettrich brings more than two decades of healthcare experience, having held roles at ZS Associates, Ogilvy and Publicis Healthcare.

Kealey, a trained anthropologist with 20 years of experience in strategy and insights, has previously held senior positions at Hall & Partners, Brado and Shapiro+Raj.

Expanding Research and Client Leadership

Maslansky + Partners is also expanding leadership responsibilities across research technology and client management.

Jaime Hodges, Senior Vice President and Head of Research & Innovation, will take on an expanded mandate overseeing both quantitative and synthetic research capabilities, including the agency’s proprietary Chorus platform.

Meanwhile, Catherine Farr, a 12-year veteran of the agency based in Washington, D.C., has been promoted to Executive Vice President. She will oversee core language strategy initiatives and key client relationships alongside her existing responsibilities for team leadership.

Focus on High-Growth Areas

The leadership changes reflect Maslansky + Partners’ strategy to strengthen its presence in healthcare and research, two areas the firm has identified as key growth opportunities.

Michael Maslansky, Chief Executive Officer, Maslansky + Partners, said the leadership reshuffle aligns with the firm’s strategic focus on scaling its high-growth healthcare and research verticals.

With the expanded leadership structure, the agency aims to deepen its specialist capabilities while strengthening collaboration across the broader Omnicom network.